Virus surge puts oil back on the defensive Virus surge puts oil back on the defensive Virus surge puts oil back on the defensive

Virus surge puts oil back on the defensive

Commodities 5 minutes to read
Ole Hansen

Head of Commodity Strategy

Summary:  Crude oil has following last week's surge already been forced back on the defensive by a resurgent virus, especially in Asia. Once again - and despite ongoing vaccine rollouts - it is raising questions about whether recently upgraded demand growth forecasts are too optimistic.

What is our trading focus?

OILUKJUN21 – Brent Crude Oil (June)
OILUSJUN21 – WTI Crude Oil (June)


Crude oil has once again been forced back on the defensive by a resurgent virus, with most regions apart from Europe experiencing rising case counts. One year ago WTI crude oil hit a historic price at minus $40/b on a combination of a pandemic-led collapse in global demand and rising supply due to a very ill-timed price war between Russia and Saudi Arabia.

Since then OPEC+ has very successfully managed to steer the market back from the brink by making sure supply was kept tight enough to support a reduction in stocks following the massive buildup last year. But just like January when the group was preparing to raise production in anticipation of a vaccine-led recovery in global demand, the market’s expectations for demand growth is once again being challenged by a record rise in coronavirus cases.

Last week crude oil recorded strong gains as the dollar weakened and after OPEC and the International Energy Agency raised their forecast for global demand growth in 2021. However, the coronavirus flare-up in Asia, a very important region in terms of demand, has sent the price of Brent crude oil lower to challenge $65.50/b, the level it broke above last week. OPEC+ has already on several occasions shown they stand ready to adjust and adapt to a changing demand outlook. With this in mind, the risk of a major correction from current levels is small but so is the upside potential. We see the price of Brent crude remain stuck in the 60’s for the remainder of this quarter or until vaccine rollouts significantly changes the demand dynamics.

Source: Saxo Group

Adding to the unease since yesterday was an industry report from the American Petroleum Institute showing a rise in US crude stocks while EIA surveys point to a drop of more than 3 million barrels.

Once the EIA report has been published at 14:30 GMT I will, as per usual, publish the result on my Twitter @ole_s_hansen

Source: Saxo Group

Saxo Capital Markets (Australia) Limited prepares and distributes information/research produced within the Saxo Bank Group for informational purposes only. In addition to the disclaimer below, if any general advice is provided, such advice does not take into account your individual objectives, financial situation or needs. You should consider the appropriateness of trading any financial instrument as trading can result in losses that exceed your initial investment. Please refer to our Analysis Disclaimer, and our Financial Services Guide and Product Disclosure Statement. All legal documentation and disclaimers can be found at

The Saxo Bank Group entities each provide execution-only service. Access and use of Saxo News & Research and any Saxo Bank Group website are subject to (i) the Terms of Use; (ii) the full Disclaimer; and (iii) the Risk Warning in addition (where relevant) to the terms governing the use of the website of a member of the Saxo Bank Group.

Saxo News & Research is provided for informational purposes, does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Bank Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. No representation or warranty is given as to the accuracy or completeness of this information. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. No Saxo Bank Group entity shall be liable for any losses that you may sustain as a result of any investment decision made in reliance on information on Saxo News & Research.

To the extent that any content is construed as investment research, such content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication.

None of the information contained here constitutes an offer to purchase or sell a financial instrument, or to make any investments.Saxo Capital Markets does not take into account your personal investment objectives or financial situation and makes no representation and assumes no liability as to the accuracy or completeness of the information nor for any loss arising from any investment made in reliance of this presentation. Any opinions made are subject to change and may be personal to the author. These may not necessarily reflect the opinion of Saxo Capital Markets or its affiliates.

Please read our disclaimers:
- Full Disclaimer (
- Analysis Disclaimer (
- Notification on Non-Independent Investment Research (

Saxo Capital Markets (Australia) Limited
Suite 1, Level 14, 9 Castlereagh St
Sydney NSW 2000

Contact Saxo

Select region


The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit

Saxo Capital Markets (Australia) Limited ABN 32 110 128 286 AFSL 280372 (‘Saxo’ or ‘Saxo Capital Markets’) is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms, Financial Services Guide, Product Disclosure Statement and Target Market Determination to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Saxo Capital Markets does not provide ‘personal’ financial product advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Capital Markets does not take into account an individual’s needs, objectives or financial situation. The Target Market Determination should assist you in determining whether any of the products or services we offer are likely to be consistent with your objectives, financial situation and needs.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the US and other countries. AppStore is a service mark of Apple Inc.

The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website is not intended for residents of the United States and Japan.

Please click here to view our full disclaimer.